Skip to main content

What is Ninlaro used for?

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 25, 2024.

Official answer

by Drugs.com

Ninlaro (ixazomib citrate) is a proteasome inhibitor used to treat patients with multiple myleoma. Multiple myeloma is a type of cancer of the bone marrow, which occurs when plasma cells grow uncontrolled.

Ninlaro comes in the from of a capsule. The Food and Drug Administration (FDA) has specifically approved Ninlaro for use in combination with a thalidomide analog called lenalidomide (Revlimid) and dexamethasone, a corticosteroid. Ninlaro is used in multiple myleoma patients who have received at least one prior therapy.

Ninlaro works by preventing the break down of all the 'garbage' proteins that myeloma cell generate, which leads to them building up and killing the myeloma cells.

Ninlaro is made by Takeda.

References

Read next

Is Velcade a type of chemotherapy?

Velcade is not a traditional form of chemotherapy (chemo). Velcade is a targeted drug therapy in the class of drugs known as proteasome inhibitors. Continue reading

Can Darzalex cure Multiple Myeloma?

Although Darzalex cannot cure multiple myeloma it can improve the quality and length of life in most people. There are two types of Darzalex: Darzalex (daratumumab) and Darzalex Faspro (daratumumab and hyaluronidase). Continue reading

How long does Velcade stay in your body?

You could expect Velcade to stay in your system ranging from 9 days (220 hours) to 44 days (1061 hours) depending on which dose you receive. Continue reading

Related medical questions

Drug information

Related support groups